{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:56Z","timestamp":1777870436206,"version":"3.51.4"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001786","name":"The University of Adelaide","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001786","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early CKD may affect pregnancy outcomes, but identifying women at most risk remains challenging. We aimed to understand the predictive role of clinical parameters in early-mid pregnancy in women with early stage CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Women with CKD stage 1\u20133 with a pregnancy\u2009&gt;\u200920\u00a0weeks gestation between 2018 and 2023 were evaluated for \u2018red flag\u2019 markers previously linked with risk of adverse pregnancy outcomes: failure of\u2009\u2265\u200910% fall in serum creatinine; urinary protein: creatinine ratio (uPCR)\u2009\u2265\u200930\u00a0mg\/mmol in second trimester; lack of physiological fall in blood pressure by mid-pregnancy. The relationship between these red flags and a composite adverse pregnancy outcome of gestational age\u2009&lt;\u200937\u00a0weeks, birth weight\u2009&lt;\u20092500\u00a0g and pre-eclampsia was determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 38 mothers with 47 deliveries, 72% of pregnancies were in women with stage 1 CKD, 38% had hypertension and 19% had pre-eclampsia. Infants had median birth weight 2895\u00a0g (IQR: 2460\u20133170) and median gestational age 37.3\u00a0weeks (IQR 35.8\u201338). Serum creatinine did not fall\u2009\u2265\u200910% in 66% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200927\/41) of women, uPCR was\u2009\u2265\u200930\u00a0mg\/mmol in 69% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200924\/35) and blood pressure did not fall in 73% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200924\/33). Eighty-six percent had one or more \u2018red flags\u2019. The composite adverse pregnancy outcome occurred in 49% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200922\/45). Women exhibiting any early-mid pregnancy red flags did not have increased rates of composite adverse pregnancy outcome (no creatinine fall, composite adverse pregnancy outcome\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200915,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.176; proteinuria\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200915, composite adverse pregnancy outcome\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.066; no blood pressure fall, composite adverse pregnancy outcome\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20091.00).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The high rate of composite adverse pregnancy outcome in early stage CKD was not associated with traditional mid-pregnancy red flags. Best models of care for this cohort remain uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s40620-025-02398-z","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T18:18:39Z","timestamp":1756232319000},"page":"2343-2351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early-mid pregnancy renal parameters and adverse pregnancy outcomes in women with early stage CKD: a case series"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4539-0957","authenticated-orcid":false,"given":"Alessandra","family":"Orsillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erandi","family":"Hewawasam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpanjali","family":"Jesudason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"2398_CR1","unstructured":"Australian Institute of Health and Welfare (2024) Chronic kidney disease: Australian facts, summary. https:\/\/www.aihw.gov.au\/reports\/chronic-kidney-disease\/chronic-kidney-disease\/contents\/summary. Accessed 9 Oct 2024"},{"key":"2398_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1681\/ASN.0000000000000053","volume":"34","author":"J Tangren","year":"2023","unstructured":"Tangren J, Bathini L, Jeyakumar N et al (2023) Pre-pregnancy eGFR and the risk of adverse maternal and fetal outcomes: a population-based study. J Am Soc Nephrol 34:656. https:\/\/doi.org\/10.1681\/ASN.0000000000000053","journal-title":"J Am Soc Nephrol"},{"key":"2398_CR3","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1093\/ndt\/gfaa247","volume":"36","author":"K Wiles","year":"2020","unstructured":"Wiles K, Webster P, Seed PT et al (2020) The impact of chronic kidney disease stages 3\u20135 on pregnancy outcomes. Nephrol Dial Transplant 36:2008\u20132017. https:\/\/doi.org\/10.1093\/ndt\/gfaa247","journal-title":"Nephrol Dial Transplant"},{"key":"2398_CR4","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s40620-018-0509-z","volume":"31","author":"Y He","year":"2018","unstructured":"He Y, Liu J, Cai Q et al (2018) The pregnancy outcomes in patients with stage 3\u20134 chronic kidney disease and the effects of pregnancy in the long-term kidney function. J Nephrol 31:953\u2013960. https:\/\/doi.org\/10.1007\/s40620-018-0509-z","journal-title":"J Nephrol"},{"key":"2398_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejogrb.2016.07.512","volume":"204","author":"J Bharti","year":"2016","unstructured":"Bharti J, Vatsa R, Singhal S et al (2016) Pregnancy with chronic kidney disease: maternal and fetal outcome. Eur J Obstet Gynecol Reprod Biol 204:83\u201387. https:\/\/doi.org\/10.1016\/j.ejogrb.2016.07.512","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2398_CR6","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1681\/ASN.2014050459","volume":"26","author":"GB Piccoli","year":"2015","unstructured":"Piccoli GB, Cabiddu G, Attini R et al (2015) Risk of adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol 26:2011. https:\/\/doi.org\/10.1681\/ASN.2014050459","journal-title":"J Am Soc Nephrol"},{"key":"2398_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.ajkd.2014.06.021","volume":"64","author":"Y Liu","year":"2014","unstructured":"Liu Y, Ma X, Lv J et al (2014) Risk factors for pregnancy outcomes in patients with IgA nephropathy: a matched cohort study. Am J Kidney Dis 64:730\u2013736. https:\/\/doi.org\/10.1053\/j.ajkd.2014.06.021","journal-title":"Am J Kidney Dis"},{"key":"2398_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.2215\/CJN.07911109","volume":"5","author":"GB Piccoli","year":"2010","unstructured":"Piccoli GB, Attini R, Vasario E et al (2010) Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol 5:844\u2013855. https:\/\/doi.org\/10.2215\/CJN.07911109","journal-title":"Clin J Am Soc Nephrol"},{"key":"2398_CR9","unstructured":"Kidney Health Australia (2024) Digital CKD Management handbook. https:\/\/kidney.org.au\/health-professionals\/ckd-management-handbook. Accessed 9 Oct 2024"},{"key":"2398_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-059160","volume":"12","author":"J Hopkins","year":"2022","unstructured":"Hopkins J, Hewawasam E, Aldridge E et al (2022) South Australian prospective cohort study evaluating outcomes of maternal kidney and cardiac disease in pregnancy: a protocol. BMJ Open 12:e059160. https:\/\/doi.org\/10.1136\/bmjopen-2021-059160","journal-title":"BMJ Open"},{"key":"2398_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/AOG.0000000000003721","volume":"135","author":"LJ Green","year":"2020","unstructured":"Green LJ, Mackillop LH, Salvi D et al (2020) Gestation-specific vital sign reference ranges in pregnancy. Obstet Gynecol 135:653. https:\/\/doi.org\/10.1097\/AOG.0000000000003721","journal-title":"Obstet Gynecol"},{"key":"2398_CR12","unstructured":"Society of Obstetric Medicine of Australia and New Zealand (2023) SOMANZ hypertension in pregnancy guideline 2023. https:\/\/www.somanz.org\/hypertension-in-pregnancy-guideline-2023\/. Accessed 27 Dec 2024"},{"key":"2398_CR13","unstructured":"Australian Institute of Health and Welfare (2024) Australia\u2019s mothers and babies, maternal medical conditions. https:\/\/www.aihw.gov.au\/reports\/mothers-babies\/australias-mothers-babies\/contents\/antenatal-period\/pre-existing-medical-conditions. Accessed 23 Aug 2024"},{"key":"2398_CR14","doi-asserted-by":"publisher","first-page":"476.e1","DOI":"10.1016\/j.ajog.2013.02.042","volume":"208","author":"C Thornton","year":"2013","unstructured":"Thornton C, Dahlen H, Korda A et al (2013) The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000\u20132008. Am J Obstet Gynecol 208:476.e1\u20135. https:\/\/doi.org\/10.1016\/j.ajog.2013.02.042","journal-title":"Am J Obstet Gynecol"},{"key":"2398_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/1753495X15576461","volume":"8","author":"NL Davidson","year":"2015","unstructured":"Davidson NL, Wolski P, Callaway LK et al (2015) Chronic kidney disease in pregnancy: maternal and fetal outcomes and progression of kidney disease. Obstet Med 8:92\u201398. https:\/\/doi.org\/10.1177\/1753495X15576461","journal-title":"Obstet Med"},{"key":"2398_CR16","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2215\/CJN.09250914","volume":"10","author":"J-J Zhang","year":"2015","unstructured":"Zhang J-J, Ma X-X, Hao L et al (2015) A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin J Am Soc Nephrol 10:1964\u20131978. https:\/\/doi.org\/10.2215\/CJN.09250914","journal-title":"Clin J Am Soc Nephrol"},{"key":"2398_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.preghy.2022.06.005","volume":"29","author":"Y He","year":"2022","unstructured":"He Y, Li Z, Chen S et al (2022) Pregnancy in patients with stage 3\u20135 CKD: maternal and fetal outcomes. Pregnancy Hypertens 29:86\u201391. https:\/\/doi.org\/10.1016\/j.preghy.2022.06.005","journal-title":"Pregnancy Hypertens"},{"key":"2398_CR18","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/ckj\/sfad044","volume":"16","author":"Z Li","year":"2023","unstructured":"Li Z, Chen S, Tan Y et al (2023) Twenty-four-hour proteinuria levels are associated with adverse pregnancy outcomes among women with CKD. Clin Kidney J 16:1634\u20131643. https:\/\/doi.org\/10.1093\/ckj\/sfad044","journal-title":"Clin Kidney J"},{"key":"2398_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1753495X231201896","volume":"17","author":"S Svetitsky","year":"2024","unstructured":"Svetitsky S, Lightstone L, Wiles K (2024) Pregnancy in women with nephrotic-range proteinuria: a retrospective cohort study. Obstet Med 17:96\u2013100. https:\/\/doi.org\/10.1177\/1753495X231201896","journal-title":"Obstet Med"},{"key":"2398_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12916-019-1399-1","volume":"17","author":"L Loerup","year":"2019","unstructured":"Loerup L, Pullon RM, Birks J et al (2019) Trends of blood pressure and heart rate in normal pregnancies: a systematic review and meta-analysis. BMC Med 17:167. https:\/\/doi.org\/10.1186\/s12916-019-1399-1","journal-title":"BMC Med"},{"key":"2398_CR21","unstructured":"NICE Guidance (2022) PLGF-based testing to help diagnose suspected preterm pre-eclampsia. https:\/\/www.nice.org.uk\/guidance\/dg49\/chapter\/1-Recommendations. Accessed 26 May 2024"},{"key":"2398_CR22","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2215\/CJN.15121219","volume":"15","author":"K Wiles","year":"2020","unstructured":"Wiles K, Chappell LC, Lightstone L et al (2020) Updates in diagnosis and management of preeclampsia in women with CKD. Clin J Am Soc Nephrol 15:1371\u20131380. https:\/\/doi.org\/10.2215\/CJN.15121219","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02398-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-025-02398-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02398-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:59:28Z","timestamp":1777564768000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/8\/2343\/8457503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["2398"],"URL":"https:\/\/doi.org\/10.1007\/s40620-025-02398-z","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Non-financial interests Professor Shilpanjali Jesudason is an Associate Editor of the Journal of Nephrology. Financial interests: none.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval was obtained from Women\u2019s and Children\u2019s Health Network Human Research Ethics Committee in Adelaide South Australia (2021\/HRE00344).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Women\u2019s and Children\u2019s Health Network Human Research Ethics Committee in Adelaide, South Australia (2021\/HRE00344) approved this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"A waiver of consent was given by the ethics committee for retrospective analysis of this cohort.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}